Boston Scientific Corporation Stock

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-05-23 pm EDT 5-day change 1st Jan Change
74.38 USD -1.31% Intraday chart for Boston Scientific Corporation -0.09% +28.66%
Sales 2024 * 15.99B Sales 2025 * 17.57B Capitalization 111B
Net income 2024 * 2.2B Net income 2025 * 2.73B EV / Sales 2024 * 7.33 x
Net Debt 2024 * 6.45B Net Debt 2025 * 3.69B EV / Sales 2025 * 6.52 x
P/E ratio 2024 *
50.6 x
P/E ratio 2025 *
41.1 x
Employees 48,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.31%
1 week-0.09%
Current month+3.49%
1 month+9.35%
3 months+11.45%
6 months+34.19%
Current year+28.66%
More quotes
1 week
74.06
Extreme 74.06
76.25
1 month
70.97
Extreme 70.97
76.25
Current year
57.11
Extreme 57.11
76.25
1 year
48.35
Extreme 48.35
76.25
3 years
34.98
Extreme 34.98
76.25
5 years
24.10
Extreme 24.1
76.25
10 years
11.10
Extreme 11.1
76.25
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 11-10-16
Director of Finance/CFO 58 96-11-30
Chief Tech/Sci/R&D Officer - 09-08-31
Members of the board TitleAgeSince
Director/Board Member 71 16-07-12
Director/Board Member 61 21-06-22
Director/Board Member 69 15-03-31
More insiders
Date Price Change Volume
24-05-23 74.38 -1.31% 5,573,943
24-05-22 75.37 -0.40% 6,390,277
24-05-21 75.67 +0.41% 5,801,543
24-05-20 75.36 +0.95% 6,534,124
24-05-17 74.65 +0.13% 6,978,299

Delayed Quote Nyse, May 23, 2024 at 04:00 pm EDT

More quotes
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
75.37 USD
Average target price
81.53 USD
Spread / Average Target
+8.18%
Consensus